Support By : Li-lab
PATHWAY_NAME | REACTOME_ID | KEGG_ID | DRUG_NAME | PUBCHEM_CID | Datasource |
---|---|---|---|---|---|
GnRH signaling pathway | R-HSA-168638 | map04912 | clorgiline | 4380 | drug-path |
Olfactory transduction | R-HSA-9751605 | map04740 | clopamide | 12492 | drug-path |
Systemic lupus erythematosus | R-HSA-977105 | map05322 | clopamide | 12492 | drug-path |
Gap junction | R-HSA-190861 | map04540 | clopamide | 12492 | drug-path |
Chronic myeloid leukemia | R-HSA-9680350 | map05220 | clopamide | 12492 | drug-path |
Olfactory transduction | R-HSA-9751605 | map04740 | zaprinast | 165580 | drug-path |
Bladder cancer | R-HSA-9700206 | map05219 | zaprinast | 165580 | drug-path |
Graft-versus-host disease | R-HSA-1643685 | map05332 | clenbuterol | 2783 | drug-path |
Jak-STAT signaling pathway | R-HSA-168638 | map04630 | clenbuterol | 2783 | drug-path |
GnRH signaling pathway | R-HSA-168638 | map04912 | clenbuterol | 2783 | drug-path |
p53 signaling pathway | R-HSA-168638 | map04115 | tyrphostin AG-825 | 6091659 | drug-path |
Alzheimer's disease | R-HSA-1643685 | 0 | tyrphostin AG-825 | 6091659 | drug-path |
Neuroactive ligand-receptor interaction | R-HSA-5632681 | map04080 | tyrphostin AG-825 | 6091659 | drug-path |
Wnt signaling pathway | R-HSA-195721 | map04310 | tyrphostin AG-825 | 6091659 | drug-path |
Huntington's disease | R-HSA-1643685 | 0 | tyrphostin AG-825 | 6091659 | drug-path |
Cell adhesion molecules (CAMs) | R-HSA-1031690 | 0 | tyrphostin AG-825 | 6091659 | drug-path |
TGF-beta signaling pathway | R-HSA-168638 | map04350 | tyrphostin AG-825 | 6091659 | drug-path |
ECM-receptor interaction | R-HSA-373711 | map04512 | tyrphostin AG-825 | 6091659 | drug-path |
Basal transcription factors | R-HSA-3232118 | map03022 | tyrphostin AG-825 | 6091659 | drug-path |
Parkinson's disease | R-HSA-1643685 | 0 | tyrphostin AG-825 | 6091659 | drug-path |